Impact of proteoglycan‐4 and parathyroid hormone on articular cartilage
dc.contributor.author | Novince, Chad M. | en_US |
dc.contributor.author | Entezami, Payam | en_US |
dc.contributor.author | Wilson, Christopher G. | en_US |
dc.contributor.author | Wang, Jason | en_US |
dc.contributor.author | Oh, Seo | en_US |
dc.contributor.author | Koh, Amy J. | en_US |
dc.contributor.author | Michalski, Megan N. | en_US |
dc.contributor.author | Sinder, Benjamin P. | en_US |
dc.contributor.author | Kozloff, Kenneth M. | en_US |
dc.contributor.author | Taichman, Russell S. | en_US |
dc.contributor.author | McCauley, Laurie K. | en_US |
dc.date.accessioned | 2013-01-03T19:35:36Z | |
dc.date.available | 2014-04-02T15:08:07Z | en_US |
dc.date.issued | 2013-02 | en_US |
dc.identifier.citation | Novince, Chad M.; Entezami, Payam; Wilson, Christopher G.; Wang, Jason; Oh, Seo; Koh, Amy J.; Michalski, Megan N.; Sinder, Benjamin P.; Kozloff, Kenneth M.; Taichman, Russell S.; McCauley, Laurie K. (2013). "Impact of proteoglycan‐4 and parathyroid hormone on articular cartilage." Journal of Orthopaedic Research 31(2): 183-190. <http://hdl.handle.net/2027.42/94686> | en_US |
dc.identifier.issn | 0736-0266 | en_US |
dc.identifier.issn | 1554-527X | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/94686 | |
dc.description.abstract | Proteoglycan‐4 ( Prg4 ) protects synovial joints from arthropathic changes by mechanisms that are incompletely understood. Parathyroid hormone (PTH), known for its anabolic actions in bone, increases Prg4 expression and has been reported to inhibit articular cartilage degeneration in arthropathic joints. To investigate the effect of Prg4 and PTH on articular cartilage, 16‐week‐old Prg4 mutant and wild‐type mice were treated with intermittent PTH (1–34) or vehicle control daily for six weeks. Analyses included histology of the knee joint, micro‐CT of the distal femur, and serum biochemical analysis of type II collagen fragments (CTX‐II). Compared to wild‐type littermates, Prg4 mutant mice had an acellular layer of material lining the surfaces of the articular cartilage and menisci, increased articular cartilage degradation, increased serum CTX‐II concentrations, decreased articular chondrocyte apoptosis, increased synovium SDF‐1 expression, and irregularly contoured subchondral bone. PTH‐treated Prg4 mutant mice developed a secondary deposit overlaying the acellular layer of material lining the joint surfaces, but PTH‐treatment did not alter signs of articular cartilage degeneration in Prg4 mutant mice. The increased joint SDF‐1 levels and irregular subchondral bone found in Prg4 mutant mice introduce novel candidate mechanisms by which Prg4 protects articular cartilage. © 2012 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 31: 183–190, 2013 | en_US |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Proteoglycan‐4 | en_US |
dc.subject.other | SDF‐1 | en_US |
dc.subject.other | Degeneration | en_US |
dc.subject.other | Cartilage | en_US |
dc.subject.other | PTH | en_US |
dc.title | Impact of proteoglycan‐4 and parathyroid hormone on articular cartilage | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, 1011 N. University Avenue, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Orthopaedic Surgery, Medical School, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Pathology, Medical School, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, 1011 N. University Avenue, Ann Arbor, Michigan. T: 1‐734‐647‐3206; F: +1‐734‐763‐5503 | en_US |
dc.identifier.pmid | 22898906 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/94686/1/22207_ftp.pdf | |
dc.identifier.doi | 10.1002/jor.22207 | en_US |
dc.identifier.source | Journal of Orthopaedic Research | en_US |
dc.identifier.citedreference | Pablos JL, Santiago B, Galindo M, et al. 2003. Synoviocyte‐derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J Immnunol 170: 2147 – 2152. | en_US |
dc.identifier.citedreference | Macica C, Liang G, Nasiri A, et al. 2011. Genetic evidence of the regulatory role of parathyroid hormone‐related protein in articular chondrocyte maintenance in an experimental mouse model. Arthritis Rheum 63: 3333 – 3343. | en_US |
dc.identifier.citedreference | Kronenberg HM. 2006. PTHrP and skeletal development. Ann N Y Acad Sci 1068: 1 – 13. | en_US |
dc.identifier.citedreference | Coles JM, Zhang L, Blum JJ, et al. 2010. Loss of cartilage structure, stiffness, and frictional properties in mice lacking PRG4. Arthritis Rheum 62: 1666 – 1674. | en_US |
dc.identifier.citedreference | Rhee DK, Marcelino J, Baker M, et al. 2005. The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J Clin Invest 115: 622 – 631. | en_US |
dc.identifier.citedreference | Schmidt TA, Gastelum NS, Nguyen QT, et al. 2007. Boundary lubrication of articular cartilage: role of synovial fluid constituents. Arthritis Rheum 56: 882 – 891. | en_US |
dc.identifier.citedreference | Kousteni S, Bilezikian JP. 2008. Cellular actions of parathyroid hormone. In: Bilezikian JP, Raisz LG, Martin TJ, editors. Principles of bone biology. 3rd ed. Burlington, MA: Elsevier Press; 2008. p 639 – 656. | en_US |
dc.identifier.citedreference | Novince CM, Michalski MN, Koh AJ, et al. 2011. Proteoglycan‐4: a dynamic regulator of skeletogenesis and PTH skeletal anabolism. J Bone Miner Res 27: 11 – 25. | en_US |
dc.identifier.citedreference | Novince CM, Koh AJ, Michalski MN, et al. 2011. Proteoglycan‐4, a novel immunomodulatory factor, regulates parathyroid hormone actions on hematopoietic cells. Am J Pathol 179: 2431 – 2442. | en_US |
dc.identifier.citedreference | Wei L, Sun X, Kanbe K, et al. 2006. Chondrocyte death induced by pathological concentration of chemokine stromal cell‐derived factor‐1. J Rheumatol 33: 1818 – 1826. | en_US |
dc.identifier.citedreference | Kanbe K, Takemura T, Takeuchi K, et al. 2004. Synovectomy reduces stromal‐cell‐derived factor‐1 (SDF‐1) which is involved in the destruction of cartilage in osteoarthritis and rheumatoid arthritis. J Bone Joint Surg Br 86: 296 – 300. | en_US |
dc.identifier.citedreference | Kanbe K, Takagishi K, Chen Q. 2002. Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell‐derived factor 1 and CXC chemokine receptor 4. Arthritis Rheum 46: 130 – 137. | en_US |
dc.identifier.citedreference | Peled A, Petit I, Kollet O, et al. 1999. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283: 845 – 848. | en_US |
dc.identifier.citedreference | Welch ID, Cowan MF, Beier F, et al. 2009. The retinoic acid binding protein CRABP2 is increased in murine models of degenerative joint disease. Arthritis Res Ther 11: R14. | en_US |
dc.identifier.citedreference | Pritzker KP, Gay S, Jimenez SA, et al. 2006. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 14: 13 – 129. | en_US |
dc.identifier.citedreference | Sampson ER, Hilton MJ, Tian Y, et al. 2011. Teriparatide as a chondroregenerative therapy for injury‐induced osteoarthritis. Sci Transl Med 3: 101ra93. | en_US |
dc.identifier.citedreference | Chang JK, Chang LH, Hung SH, et al. 2009. Parathyroid hormone 1‐34 inhibits terminal differentiation of human articular chondrocytes and osteoarthritis progression in rats. Arthritis Rheum 60: 3049 – 3060. | en_US |
dc.identifier.citedreference | Jay GD, Fleming BC, Watkins BA, et al. 2010. Prevention of cartilage degeneration and restoration of chondroprotection by lubricin tribosupplementation in the rat following anterior cruciate ligament transection. Arthritis Rheum 62: 2382 – 2391. | en_US |
dc.identifier.citedreference | Flannery CR, Zoller R, Corcoran C, et al. 2009. Prevention of cartilage degeneration in a rat model of osteoarthritis by intraarticular treatment with recombinant lubricin. Arthritis Rheum 60: 840 – 847. | en_US |
dc.identifier.citedreference | Ungethuem U, Haeupl T, Witt H, et al. 2010. Molecular signatures and new candidates to target the pathogenesis of rheumatoid arthritis. Physiol Genomics 42A: 267 – 282. | en_US |
dc.identifier.citedreference | Elsaid KA, Fleming BC, Oksendahl HL, et al. 2008. Decreased lubricin concentrations and markers of joint inflammation in the synovial fluid of patients with anterior cruciate ligament injury. Arthritis Rheum 58: 1707 – 1715. | en_US |
dc.identifier.citedreference | Marcelino J, Carpten JD, Suwairi WM, et al. 1999. CACP, encoding a secreted proteoglycan, is mutated in camptodactyly‐arthropathy‐coxa vara‐pericarditis syndrome. Nat Genet 23: 319 – 322. | en_US |
dc.identifier.citedreference | Drewniak EL, Jay GD, Fleming BC, et al. 2012. Cyclic loading increases friction and changes cartilage surface integrity in lubricin mutant mouse knees. Arthritis Rheum 64: 465 – 473. | en_US |
dc.identifier.citedreference | Jay GD, Torres JR, Rhee DK, et al. 2007. Association between friction and wear in diarthrodial joints lacking lubricin. Arthritis Rheum 56: 3662 – 3669. | en_US |
dc.identifier.citedreference | Radin EL, Rose RM. 1986. Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop Relat Res 213: 34 – 40. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.